Pasquale Zizza

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Multi-omics analyses integration reveals a novel TRF2-miR-181a-5p-S100A10 regulatory axis in colon cancer.

Multi-omics analyses integration reveals a novel TRF2-miR-181a-5p-S100A10 regulatory axis in colon cancer.

Journal: Cellular & molecular biology letters
Published: January 31, 2025

Core-Extended Naphthalene Diimide Dyads as Light-Up Probes with Targeted Cytotoxicity Toward Tumor Cells.

Core-Extended Naphthalene Diimide Dyads as Light-Up Probes with Targeted Cytotoxicity Toward Tumor Cells.

Journal: Biomolecules
Published: January 10, 2025

Expanding the Functions of KHSRP Protein: Insights into DNA G-Quadruplex Binding.

Expanding the Functions of KHSRP Protein: Insights into DNA G-Quadruplex Binding.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 22, 2024

Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes.

Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes.

Journal: Nucleic acids research
Published: June 17, 2024

TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.

TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.

Journal: Cell death & disease
Published: May 28, 2024

Therapeutic Use of G4-Ligands in Cancer: State-of-the-Art and Future Perspectives.

Therapeutic Use of G4-Ligands in Cancer: State-of-the-Art and Future Perspectives.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 18, 2024

Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activity.

Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activity.

Journal: Nucleic acids research
Published: April 15, 2024

TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.

TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 27, 2023

Selective Targeting of Cancer-Related G-Quadruplex Structures by the Natural Compound Dicentrine.

Selective Targeting of Cancer-Related G-Quadruplex Structures by the Natural Compound Dicentrine.

Journal: International journal of molecular sciences
Published: January 21, 2023

Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors.

Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors.

Journal: Aging cell
Published: January 13, 2023

The telomeric protein TERF2/TRF2 impairs HMGB1-driven autophagy.

The telomeric protein TERF2/TRF2 impairs HMGB1-driven autophagy.

Journal: Autophagy
Published: October 31, 2022

TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer.

TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer.

Journal: Cancer letters
Published: November 09, 2021
Showing 1-12 of 44

Last Updated: 09/26/2026